Letter: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30).
作者信息
Jeon Jae Han
机构信息
Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Korea.
出版信息
Diabetes Metab J. 2017 Apr;41(2):150-151. doi: 10.4093/dmj.2017.41.2.150.
Abstract
摘要
相似文献
1
Letter: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30).信函：中等强度他汀类药物对韩国2型糖尿病患者血脂异常的治疗效果（《糖尿病代谢杂志》2017年；第41卷：第23 - 30页）
Diabetes Metab J. 2017 Apr;41(2):150-151. doi: 10.4093/dmj.2017.41.2.150.
2
Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30).回应：中等强度他汀类药物治疗韩国2型糖尿病患者血脂异常的疗效（《糖尿病代谢杂志》2017年；41:23 - 30）
Diabetes Metab J. 2017 Apr;41(2):152-153. doi: 10.4093/dmj.2017.41.2.152.
3
Letter: Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data (Diabetes Metab J 2017;41:393-404).信函：基于标准化临床数据的韩国长期2型糖尿病视网膜病变患者的特征：一项研究（《糖尿病代谢杂志》2017年；41:393 - 404）
Diabetes Metab J. 2017 Dec;41(6):492-493. doi: 10.4093/dmj.2017.41.6.492.
4
Letter: predictive clinical parameters for the therapeutic efficacy of sitagliptin in korean type 2 diabetes mellitus (diabetes metab j 2011;35:159-65).信函：西他列汀治疗韩国2型糖尿病疗效的预测性临床参数（《糖尿病与代谢杂志》2011年；35:159 - 165）
Diabetes Metab J. 2011 Jun;35(3):298-9. doi: 10.4093/dmj.2011.35.3.298. Epub 2011 Jun 30.
5
Letter: genome-wide association study identifies two novel Loci with sex-specific effects for type 2 diabetes mellitus and glycemic traits in a korean population (diabetes metab j 2014;38:375-87).信函：全基因组关联研究在韩国人群中鉴定出两个对2型糖尿病和血糖性状具有性别特异性效应的新基因座（《糖尿病与代谢杂志》2014年；38:375 - 87）
Diabetes Metab J. 2014 Dec;38(6):484-6. doi: 10.4093/dmj.2014.38.6.484.
6
Letter: Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005 (Diabetes Metab J 2012;36:43-55).信函：韩国成年人血脂异常患病率：1998 - 2005年韩国国家健康与营养调查（《糖尿病代谢杂志》2012年；36:43 - 55）
Diabetes Metab J. 2012 Apr;36(2):163-4. doi: 10.4093/dmj.2012.36.2.163. Epub 2012 Apr 17.
7
Letter: the prevalence of peripheral arterial disease in korean patients with type 2 diabetes mellitus attending a university hospital (diabetes metab j 2011;35:543-50).信函：大学医院中2型糖尿病韩国患者外周动脉疾病的患病率（《糖尿病与代谢杂志》2011年；35:543 - 50）
Diabetes Metab J. 2011 Dec;35(6):637-9. doi: 10.4093/dmj.2011.35.6.637. Epub 2011 Dec 26.
8
Letter: Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2015;39:342-7).信函：2型糖尿病患者中双肽基肽酶-4抑制剂疗效的预测因素（《糖尿病代谢杂志》2015年；39:342 - 347）
Diabetes Metab J. 2015 Oct;39(5):444-5. doi: 10.4093/dmj.2015.39.5.444. Epub 2015 Oct 22.
9
Re-Evaluation of Efficacy of Moderate-Intensity Statins in Korean Patients with Type 2 Diabetes Mellitus.韩国2型糖尿病患者中高强度他汀类药物疗效的重新评估
Diabetes Metab J. 2017 Feb;41(1):20-22. doi: 10.4093/dmj.2017.41.1.20.
10
Letter: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7).信函：瑞巴派特对2型糖尿病患者胃肠道症状的影响（《糖尿病代谢杂志》2016年；40:240 - 247）
Diabetes Metab J. 2016 Aug;40(4):334-5. doi: 10.4093/dmj.2016.40.4.334.
本文引用的文献
1
Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus.中等强度他汀类药物治疗韩国2型糖尿病患者血脂异常的疗效
Diabetes Metab J. 2017 Feb;41(1):23-30. doi: 10.4093/dmj.2017.41.1.23. Epub 2016 Dec 16.
2
9. Cardiovascular Disease and Risk Management.9. 心血管疾病与风险管理。
Diabetes Care. 2017 Jan;40(Suppl 1):S75-S87. doi: 10.2337/dc17-S012.
3
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.他汀类药物用于成人心血管疾病的一级预防：美国预防服务工作组推荐声明
JAMA. 2016 Nov 15;316(19):1997-2007. doi: 10.1001/jama.2016.15450.
4
Comparison of different statin therapy to change low-density lipoprotein cholesterol and high-density lipoprotein cholesterol level in Korean patients with and without diabetes.不同他汀类药物疗法对韩国糖尿病患者和非糖尿病患者低密度脂蛋白胆固醇及高密度脂蛋白胆固醇水平变化的比较。
J Clin Lipidol. 2016 May-Jun;10(3):528-537.e3. doi: 10.1016/j.jacl.2015.12.013. Epub 2015 Dec 23.
5
Statin adherence and LDL cholesterol levels. Should we assess adherence prior to statin upgrade?他汀类药物的依从性和 LDL 胆固醇水平。我们是否应该在升级他汀类药物之前评估其依从性？
Eur J Intern Med. 2015 May;26(4):268-72. doi: 10.1016/j.ejim.2015.02.014. Epub 2015 Mar 11.
6
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45. doi: 10.1161/01.cir.0000437738.63853.7a. Epub 2013 Nov 12.
Zotero 插件